Avaleht › Difuusne suure B-raku lümfoom › Illinois › Chicago
Difuusne suure B-raku lümfoom kliinilised uuringud linnas Chicago, IL
18 uuringut haiguse Difuusne suure B-raku lümfoom jaoks otsivad osalejaid linnas Chicago ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
VärbamineFaas 2
- Northwestern University - Feinberg School of Medicine, Chicago
- Rush University Medical Center, Chicago
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
VärbamineFaas 2
- Northwestern University, Chicago
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
VärbamineFaas 2
- University of Chicago Medical Center ( Site 0126), Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
VärbamineFaas 1
- The University of Chicago Medical Center (UCMC), Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
VärbamineFaas 1
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
VärbamineFaas 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
VärbamineFaas 1/2
- University of Chicago Medical Center, Chicago
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
VärbamineVaatlusuuring
- Robert H Lurie Cancer Center, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
VärbamineFaas 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
VärbamineFaas 2
- Robert H Lurie Cancer Center, Chicago
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
VärbamineFaas 1
- University of Illinois at Chicago, Chicago
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
VärbamineFaas 1
- Northwestern University, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
VärbamineFaas 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- The University of Chicago Medical Center, Chicago
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
VärbamineFaas 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
VärbamineFaas 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
VärbamineFaas 1
- University of Chicago, Chicago
Difuusne suure B-raku lümfoom uuringud teistes linnades
- New York City, NY21 uuringut
- Baldwin Park, CA19 uuringut
- Houston, TX17 uuringut
- Los Angeles, CA17 uuringut
- Boston, MA16 uuringut
- Milwaukee, WI16 uuringut
- Nashville, TN15 uuringut
- Portland, OR15 uuringut
- Philadelphia, PA15 uuringut
- Durham, NC14 uuringut
- Dallas, TX13 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Chicago
- Mitteväikerakuline kopsuvähk61 uuringut
- Rinnavähk58 uuringut
- Vähk (kõik liigid)51 uuringut
- Metastaatiline vähk45 uuringut
- Eesnäärmevähk45 uuringut
- Rasvumine41 uuringut
- Kopsuvähk41 uuringut
- Munasarjavähk36 uuringut
- Insult34 uuringut
- Käär- ja pärasoolevähk33 uuringut
- Südamepuudulikkus31 uuringut
- Ülekaalulisus28 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.